PPARGC1A and Insulin resistance: The present study is of substantial interest from both a basic and a clinical science perspective, defining the existence of an EET-PGC-1α-HO-1 regulatory axis that can ameliorate the deleterious effects of HF diet-induced metabolic abnormalities, including insulin resistance, and prediabetic conditions involving adipose tissues.